Matricelf Ltd. Logo

Matricelf Ltd.

MTLF | TA

Overview

Corporate Details

ISIN(s):
IL0011767915
LEI:
Country:
Israel
Address:
3 Golda Meir Street, 7651713 Ness Zion
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Matricelf Ltd. is a biotechnology company pioneering personalized regenerative medicine through its proprietary platform for autologous 3D tissue engineering. The company's technology enables the creation of functional tissue implants using a patient's own cells and biological materials. The process involves differentiating induced Pluripotent Stem Cells (iPSCs) within a personalized hydrogel derived from the patient's omental extracellular matrix. This fully autologous approach aims to provide one-time, curative therapies with a reduced risk of immune rejection. Matricelf's primary focus is on developing a treatment for spinal cord injuries by engineering neural implants to restore lost function. The platform's potential applications extend to other conditions, including stroke, traumatic brain injury, and myocardial infarction.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Matricelf Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-09-08 20:40
Investor Presentation
COMPANY'S PRESENTATION
Hebrew (modern) 2.3 MB
2024-09-08 20:40
Pre-Annual General Meeting Information
COMPANY'S PRESENTATION
Russian 42.8 KB
2024-03-27 15:30
Investor Presentation
INVESTORS PRESENTATION
English 2.7 MB
2024-03-27 15:30
Pre-Annual General Meeting Information
INVESTORS PRESENTATION
Russian 43.3 KB
2023-02-14 16:31
Investor Presentation
Corporate Presentation - February2023
English 1.1 MB
2023-02-14 16:31
Regulatory News Service
Corporate Presentation - February2023
Russian 42.7 KB
2022-03-16 10:59
Investor Presentation
INVESTORS PRESENTATION
English 2.7 MB
2022-03-16 10:59
Pre-Annual General Meeting Information
INVESTORS PRESENTATION
Russian 41.6 KB
2021-06-17 18:14
Regulatory News Service
Opening of Trading On Sunday June 20, 2021, Appointment of a Market Maker
Hebrew (modern) 256.5 KB
2021-06-14 14:20
Regulatory News Service
Identifying Details of New Security: MATRICELF, MATRICELF.W1
Hebrew (modern) 177.2 KB

Automate Your Workflow. Get a real-time feed of all Matricelf Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Matricelf Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN